Companies with a Future performance score of at least 3, ordered by Future performance score.
Enzymatica AB, a life science company, develops and sells medical devices for infection-related diseases in Sweden and internationally.
Genovis AB (publ.) develops, produces, and sells tools for developing drugs for customers in the medical device and pharmaceutical industries.
Camurus AB (publ), a pharmaceutical company, develops and commercializes pharmaceuticals for serious and chronic conditions in Europe, North America, and Asia.
BioInvent International AB (publ) focuses on the research and development of immunomodulating antibodies for the treatment of cancer in Sweden, Europe, the United States, and internationally.
Calliditas Therapeutics AB (publ) operates as a biopharmaceutical company in Stockholm, Sweden.
Cellink AB (publ) designs and develops bioprinting technologies that enable researchers to 3D print organs and tissue for applications primarily in pharmaceutical to cosmetic industries worldwide.
Nanologica AB (publ) develops nanoporous silica for applications in the life science industry.
Spago Nanomedical AB (publ) develops nanomaterials for cancer diagnostics and treatment.
Intervacc AB (publ), a biotechnology company, engages in the research and development of veterinary vaccines using recombinant proteins for animal health.
Swedencare AB (publ), together with its subsidiaries, develops, manufactures, distributes, and sells healthcare products.
Bonesupport Holding AB (publ), an orthobiologics company, develops and commercializes injectable bioceramic bone graft substitutes for the treatment of bone voids in Sweden, rest of Europe, North America, and internationally.
Oasmia Pharmaceutical AB (publ) develops, manufactures, markets, and sells drugs in the field of human and veterinary oncology primarily in Sweden.
Vitrolife AB (publ), a medical device company, develops, produces, and markets products for assisted reproduction.
Orexo AB (publ), a specialty pharmaceutical company, and its subsidiaries develop and commercialize pharmaceuticals and digital therapies in the United States.
Idogen AB (publ), a biotechnology company, develops tolerogenic cell therapies to prevent the patient’s immune system from attacking biological agents, transplanted organs, or the body’s own cells or tissues in Sweden.
Recipharm AB (publ) provides contract development and manufacturing solutions to the pharmaceutical industry in Sweden, Italy, France, India, Spain, Portugal, Germany, and internationally.
MedCap AB (publ) is a private equity firm specializing in investments in secondary direct, later stage, industry consolidation, growth capital, middle market, mature, turnarounds, buyout.
BioGaia AB (publ) develops, markets, and sells probiotic products with documented health benefits worldwide.
Probi AB (publ), a bioengineering company, researches, develops, manufactures, markets, and sells probiotics for food, health, and pharmaceutical companies.
Oncopeptides AB (publ), a pharmaceutical company, develops pharmaceuticals drugs for the treatment of cancer.
Swedish Orphan Biovitrum AB (publ), an integrated biotechnology company, researches, develops, manufactures, and sells pharmaceuticals in the therapeutic areas of haematology, immunology, and genetic and metabolic diseases.